Inflammatory bowel disease: between genetics and microbiota N Younis, R Zarif, R Mahfouz Molecular biology reports 47, 3053-3063, 2020 | 117 | 2020 |
Visfatin: A possible role in cardiovasculo-metabolic disorders A Dakroub, S A. Nasser, N Younis, H Bhagani, Y Al-Dhaheri, G Pintus, ... Cells 9 (11), 2444, 2020 | 80 | 2020 |
Metal-based nanoparticles: Promising tools for the Management of Cardiovascular Diseases NK Younis, JA Ghoubaira, EP Bassil, HN Tantawi, AH Eid Nanomedicine: Nanotechnology, Biology and Medicine, 102433, 2021 | 57 | 2021 |
Lipid-lowering therapies for atherosclerosis: statins, fibrates, ezetimibe and PCSK9 monoclonal antibodies AH Ali, N Younis, R Abdallah, F Shaer, A Dakroub, MA Ayoub, R Iratni, ... Current Medicinal Chemistry 28 (36), 7427-7445, 2021 | 44 | 2021 |
Hydroxychloroquine in COVID-19 patients: pros and cons NK Younis, RO Zareef, SN Al Hassan, F Bitar, AH Eid, M Arabi Frontiers in Pharmacology 11, 597985, 2020 | 39 | 2020 |
Cardiac manifestations in COVID‐19 patients: A focus on the pediatric population T Abi Nassif, G Fakhri, NK Younis, R Zareef, F Al Amin, F Bitar, M Arabi Canadian Journal of Infectious Diseases and Medical Microbiology 2021 (1 …, 2021 | 36 | 2021 |
Nanoparticles: attractive tools to treat colorectal cancer NK Younis, R Roumieh, EP Bassil, JA Ghoubaira, F Kobeissy, AH Eid Seminars in Cancer Biology 86, 1-13, 2022 | 34 | 2022 |
COVID-19 in pediatric patients: a focus on CHD patients RO Zareef, NK Younis, F Bitar, AH Eid, M Arabi Frontiers in Cardiovascular Medicine 7, 612460, 2020 | 33 | 2020 |
Aspirin in COVID-19: Pros and cons R Zareef, M Diab, T Al Saleh, A Makarem, NK Younis, F Bitar, M Arabi Frontiers in Pharmacology 13, 849628, 2022 | 26 | 2022 |
COVID-19: potential therapeutics for pediatric patients NK Younis, RO Zareef, G Fakhri, F Bitar, AH Eid, M Arabi Pharmacological Reports 73, 1520-1538, 2021 | 23 | 2021 |
COVID-19 in the MENA Region: Facts and Findings NK Younis, M Rahm, F Bitar, M Arabi The Journal of Infection in Developing Countries 15 (03), 342-349, 2021 | 17 | 2021 |
The era of the coronavirus disease 2019 pandemic: a review on dynamics, clinical symptoms and complications, diagnosis, and treatment NK Younis, RO Zareef, MAN Maktabi, R Mahfouz Genetic Testing and Molecular Biomarkers 25 (2), 85-101, 2021 | 13 | 2021 |
Inflammatory bowel disease: A key role for microbiota? R Zareef, N Younis, R Mahfouz Meta Gene 25, 100713, 2020 | 13 | 2020 |
Ivabradine: a potential therapeutic for children with refractory SVT NK Younis, B Abi-Saleh, F Al Amin, O El Sedawi, C Tayeh, F Bitar, ... Frontiers in Cardiovascular Medicine 8, 660855, 2021 | 11 | 2021 |
Microneedle‐Mediated Delivery of Immunomodulators Restores Immune Privilege in Hair Follicles and Reverses Immune‐Mediated Alopecia N Younis, N Puigmal, AE Kurdi, A Badaoui, D Zhang, C Morales‐Garay, ... Advanced Materials 36 (31), 2312088, 2024 | 6 | 2024 |
Nanomedicine for cancer NK Younis, HM Yassine, AH Eid Current Medicinal Chemistry 30 (23), 2592-2594, 2023 | 6 | 2023 |
Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution A Halawi, AB El Kurdi, KA Vernon, Z Solhjou, JY Choi, AJ Saad, ... Frontiers in Immunology 14, 1139358, 2023 | 6 | 2023 |
Balloon valvuloplasty for congenital aortic stenosis: experience at a tertiary center in a developing country FA Charafeddine, HB Houssein, NB Kibbi, IM El-Rassi, AM Tabbakh, ... Journal of Interventional Cardiology 2021 (1), 6681693, 2021 | 6 | 2021 |
2-Nucleobase-substituted 4, 6-diaminotriazine analogs: synthesis and anti-cancer activity in 5-fluorouracil-sensitive and resistant colorectal cancer cells K Hamze, RH Abdallah, NK Younis, M Fardoun, N Darwiche, F Kobeissy, ... Current Medicinal Chemistry 30 (26), 3032-3049, 2023 | 5 | 2023 |
Neglected Tropical Diseases in Lebanon W Alam, T Mobayed, N Younis, R Zarif, N Bizri, H Tamim, U Musharrafieh, ... Acta Parasitologica 67 (2), 809-819, 2022 | 5 | 2022 |